$SHIB

#ShibaSwap is going multi-chain, operating on both #Shibarium and Ethereum.

Who knows what the future holds? 👀
We're expanding our horizons.

Don't forget, $Bone is the Shibarium gas fee token. IYKYK 😉 pic.twitter.com/ZCFep8AIKG

— 𝐋𝐔𝐂𝐈𝐄 | SHIB.IO (@LucieSHIB) April 29, 2024

$Shib Army Ranks

$SHIB Shiba Inu has secured another significant collaboration, teaming up with the Content Delivery and Security Association (CDSA) to address AI-driven content challenges through Shibarium.

Shiba Inu Joins Industry Giants Apple and Netflix at CDSA to Secure the Future of Entertainment https://t.co/OS4E6ArEIB

— 𝐋𝐔𝐂𝐈𝐄 | SHIB.IO (@LucieSHIB) April 12, 2024

Nice MACD $ABQQ

$SHIB ,A Shiba Inu Whale Just Bought 551 Billion SHIB: Last Time They Did That, SHIB Pumped 1,100% - Benzinga

A Shiba Inu Whale Just Bought 551 Billion SHIB: Last Time They Did That, SHIB Pumped 1,100% - Benzinga$SHIB #SHIB #ShibaInu #Shibarium #SHIBARMY #BONE #LEASH #RyoshiL2 https://t.co/sUYAqF2ErE

— SHIB Bezos (@BezosCrypto) April 6, 2024

$SHIB Burn https://www.shibburn.com/

as is your come back making it personal 🤡

That is nothing new 😂

$ABQQ

Just updated 235 millions shares cancellation from TA $ABQQ https://t.co/gVC8EyHgyp pic.twitter.com/RNLuO58fV3

— ABQQ (@ABIntlGroup) March 20, 2024

more than most realize 1/2ing is around the corner ,it should make for some interesting times

$SHIB

The $Shib #Ai bot powered by @badideaai now serves @Shibtoken global room along with 28 $Shib ecosystem rooms with a total population of 105,000 users. As a whole the bot now covers 250 @telegram groups spanning a total population of just under a quarter of a million users. pic.twitter.com/sHrkDuTBmL

— Bad Idea AI (@badideaai) March 15, 2024

just like what I was saying

this shit just can't hold any gains

$SHIB going Higher

Here we go again $SHIB 🔥

This is bullish 👇 pic.twitter.com/xVbaB7ziGh

— $SHIB BPP (@ShibBPP) March 13, 2024

$SHIB 10X

Wow! Another important component in the Shib global strategy... #dailynews. Sourcing from all over crypto and beyond, now all the incredible #SHIB and #Shibarium projects can get the shine they deserve. The year is just getting started for us, woof! https://t.co/oJQAk362UP

— Shytoshi Kusama™ (@ShytoshiKusama) March 13, 2024

$SHIB GOLD.

📢 Attention #SHIBARMY 🐾 Get ready to wag your tails in excitement because Shib News Daily is now live! This is your go-to source for the latest Shib gossip 📰 Dive in here: https://t.co/Hqdb5vNbGe #ShibNewsDaily https://t.co/RHQ7iAIoJK

— Shib (@Shibtoken) March 13, 2024

1,380,905 holders
https://etherscan.io/token/0x95ad61b0a150d79219dcf64e1e6cc01f0b64c4ce

this shit just can't hold any gains

$SHIB

🚨NEW COINS ALERT🚨

You can now access a variety of new coins at Localcoin ATMs across Australia, including @Ripple (XRP), @litecoin (LTC), @ethereum (ETH), @Cardano (ADA), @Shibtoken (SHIB), and USD Coin (USDC).

Jump into crypto with a diverse range of coins today! pic.twitter.com/xzaXLR2hnM

— Localcoin Bitcoin ATM (@LocalcoinATM) November 13, 2023

just keep adding $SHIB

another win for we the people

$PPJE web page is down.... Error establishing a database connection

$ABQQ has decided not to pursue the collaboration with Metatron Apps as previously planned. Instead, the company has opted to move forward with an other company. This strategic decision reflects ABQQ's commitment to exploring alternative opportunities that align more closely with…

— ABQQ (@ABIntlGroup) March 3, 2024

We don't have time to update posts on this account because Amy no longer works for it. However, we are working hard to run our business and create value for our customers and shareholders. We will keep you updated on upcoming events via press releases here or on the newswire.… https://t.co/nnbRUtBC1Z

— ABQQ (@ABIntlGroup) March 2, 2024

Wow. 🔥 LISTEN TO THIS WHOLE THING! Share everywhere.

Is Trudeau finished?! Exposed!

Collusion with Beijing, bio-terrorisim, stolen elections, Wuhan lab?

Trudeau just got CAUGHT covering it all up.

Global Military Operations. We ARE taking down the NWO.… pic.twitter.com/3zxevuezXv

— Joe Rambo (@BrainStorm_Joe) March 1, 2024

Wow. 🔥 LISTEN TO THIS WHOLE THING! Share everywhere.

Is Trudeau finished?! Exposed!

Collusion with Beijing, bio-terrorisim, stolen elections, Wuhan lab?

Trudeau just got CAUGHT covering it all up.

Global Military Operations. We ARE taking down the NWO.… pic.twitter.com/3zxevuezXv

— Joe Rambo (@BrainStorm_Joe) March 1, 2024

Metatron Apps and AB International Group Join Forces to Launch AI enhanced Movie Streaming Hub $ABQQ

$ABQQ press release https://t.co/fMZckrS75p $MRNJ

— ABQQ (@ABIntlGroup) February 27, 2024

$ABQQ on X

$ABQQ We’re negotiating with several shareholders, who expressed their willingness to cancel most of their ABQQ common shares in exchange for equity interests in https://t.co/g46POlQJOj to support the company in achieving its goals. They continued to hold some common shares until…

— ABQQ (@ABIntlGroup) February 26, 2024

$ABQQ is pleased to inform everyone that although it has sold this AI project, it still retains the right to use it for free. The project is progressing smoothly. https://t.co/Y9QkOZPnzm

— ABQQ (@ABIntlGroup) February 26, 2024

Shibarium to Start Auto-Burning SHIB Tokens: A Boost for Shiba Inu’s Scarcity

Shibarium, Shiba Inu’s Layer-2 network, will start automatic burning of SHIB tokens from January 2024, transitioning away from manual token burns.

The network will allocate 70% of its base fees to SHIB token burns, aiming to reduce circulating supply and potentially increase the token’s value.
The Dawn of Automated Burns in Shiba Inu Ecosystem

Shiba Inu is on the brink of a pivotal transformation with its Layer-2 network, Shibarium, set to implement automated SHIB token burns from January 2024. This strategic move signals the end of manual burns, marking a significant shift in how the token’s circulating supply is managed.

Understanding Shibarium’s Automated Burn Mechanism

Shibarium operates by charging users fees for transactions on its network. A substantial portion of these fees, amounting to 70%, is allocated to the automatic burning of SHIB tokens. This mechanism is structured on a 70-30 ratio, where the remaining 30% of the fees are dedicated to maintaining the network’s functionality.

Implications for Shiba Inu’s Tokenomics

The automated burning process is a critical development for Shiba Inu’s goal of reducing its circulating supply. By systematically eliminating a portion of SHIB tokens, Shibarium aims to create scarcity, potentially enhancing the token’s value over time. However, the effectiveness of this strategy and the exact number of tokens to be burned initially remain to be seen.

The success of reaching significant price milestones, such as the $0.01 mark, hinges on the network’s ability to burn trillions of tokens annually. If Shibarium‘s burning mechanism fails to achieve this, the goal of significantly increasing SHIB’s value may remain elusive.

Current Market Standing of Shiba Inu

As of the current market analysis, Shiba Inu is trading at $0.00000955, experiencing a downturn of nearly 12% in the 24-hour trading window. The token is still recovering from its all-time high of $0.00008616, reached in October 2021, currently down by approximately 89%.

A Turning Point for Shiba Inu

The introduction of automated burns by Shibarium marks a turning point for Shiba Inu. This evolution in the token’s management strategy reflects a sophisticated approach to influencing its market value and supply dynamics. As Shibarium begins its operations, the crypto community and SHIB investors are keenly observing how this innovative move will shape the future trajectory of the popular meme token.

https://www.binance.com/en/feed/post/2305607305057

$ABQQ looking better ,Thanks

The film “YOLO” gross box office 803 million yuan. $ABQQ pic.twitter.com/Mnprh1UjzT

— ABQQ (@ABIntlGroup) February 11, 2024

$BRTX. so sad
BIORESTORATIVE THERAPIES INC
$1.57-1.88 (-54.49%)

$SHIB BURN

BREAKING‼️

Ryoshi network uses $SHIB as native Gas token and burns $SHIB.https://t.co/eDEaLrSzsC

— Shiba Inu News (@ShibalnuNews) February 6, 2024

$SHIB BURN

🎉 Exciting News! 🐕 Starting today @bpp_media is thrilled to announce that with @SHIBBPP , we'll burn 100% of our Twitter ads revenue in $SHIB via Coinbase, as a way to give back to our amazing community! 🔥 Let's make a difference together! 🚀 #SHIB #CryptoCommunity #GiveBack pic.twitter.com/qBWHINudR4

— $SHIB BPP (@ShibBPP) February 5, 2024

I say Thank you !!!

$ABQQ

Item 1.01 Entry into a Material Definitive Agreement.



On January 26, 2024, AB International Group Corp. (the “Company”) entered into Repurchase Agreements with six shareholders, all non-affiliates of the Company, pursuant to which the Company agreed to repurchase shares of their Common Stock, $0.001 par value, amounting to 45,173,980 shares for cancellation. The price to be paid by the Company under the Repurchase Agreements is $112,935, which will be funded with cash on hand.

https://ih.advfn.com/stock-market/USOTC/ab-pk-ABQQ/stock-news/93157922/form-8-k-current-report

sure has - $BRTX

BioRestorative Therapies, Inc. (“BioRestorative”, “$BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced the public availability of a poster, presented yesterday at the Orthopaedic Research Society (ORS) 2024 Annual Meeting, which describes preliminary 26 and 52 week blinded data from the ongoing Phase 2 clinical trial of the Company’s lead clinical candidate, BRTX-100, in subjects with chronic lumbar disc disease (“cLDD”).
The presented poster, titled “Autologous Stem Cell Therapy for Chronic Lumbar Disc Disease; Initial Phase 2 Clinical Safety and Feasibility Data of Intradiscal Injections of Hypoxic Cultured Mesenchymal Stem Cells” can be accessed on the Company’s website at www.biorestorative.com under “Scientific Publications” in the Product Candidate section. During a webcasted conference call scheduled for 8:30am EST today, BioRestorative management will be available to discuss data from the presentation as well as provide a clinical update.

Previous clinical studies have demonstrated that the harsh microenvironment of the disc could impact cell dose viability and result in a non-efficacious or the worsening of clinical outcomes. Although this is blinded and early clinical data, it is important to note that the Visual Analog Scale, Oswestry Disability Index, Roland Morris Disability Questionnaire, and Functional Rating Index collected at weeks 26 and 52 post-injection demonstrated a positive trend compared to baseline. In addition to safety outcomes, changes to these pain and function scales compared to baseline are used by the U.S. Food and Drug Administration (FDA) to determine whether the trial will be allowed to proceed and ultimately gain Biologics License Application (BLA) approval.

“We are thrilled with the progress of our ongoing clinical development programs. With regard to the Phase 2 study investigating the use of BRTX-100 in the treatment of cLDD, we are strongly encouraged by the preliminary data presented at ORS 2024. The preliminary clinical data shows meaningful signals in patients enrolled in the study and, importantly, no notable safety signals,” said Lance Alstodt, Chief Executive Officer of BioRestorative.
https://ih.advfn.com/stock-market/NASDAQ/biorestorative-therapies-BRTX/stock-news/93206255/biorestorative-therapies-presents-preliminary-clin

$BRTX BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

BioRestorative Therapies, Inc. (“BioRestorative”, “$BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced the public availability of a poster, presented yesterday at the Orthopaedic Research Society (ORS) 2024 Annual Meeting, which describes preliminary 26 and 52 week blinded data from the ongoing Phase 2 clinical trial of the Company’s lead clinical candidate, BRTX-100, in subjects with chronic lumbar disc disease (“cLDD”).
The presented poster, titled “Autologous Stem Cell Therapy for Chronic Lumbar Disc Disease; Initial Phase 2 Clinical Safety and Feasibility Data of Intradiscal Injections of Hypoxic Cultured Mesenchymal Stem Cells” can be accessed on the Company’s website at www.biorestorative.com under “Scientific Publications” in the Product Candidate section. During a webcasted conference call scheduled for 8:30am EST today, BioRestorative management will be available to discuss data from the presentation as well as provide a clinical update.

Previous clinical studies have demonstrated that the harsh microenvironment of the disc could impact cell dose viability and result in a non-efficacious or the worsening of clinical outcomes. Although this is blinded and early clinical data, it is important to note that the Visual Analog Scale, Oswestry Disability Index, Roland Morris Disability Questionnaire, and Functional Rating Index collected at weeks 26 and 52 post-injection demonstrated a positive trend compared to baseline. In addition to safety outcomes, changes to these pain and function scales compared to baseline are used by the U.S. Food and Drug Administration (FDA) to determine whether the trial will be allowed to proceed and ultimately gain Biologics License Application (BLA) approval.

“We are thrilled with the progress of our ongoing clinical development programs. With regard to the Phase 2 study investigating the use of BRTX-100 in the treatment of cLDD, we are strongly encouraged by the preliminary data presented at ORS 2024. The preliminary clinical data shows meaningful signals in patients enrolled in the study and, importantly, no notable safety signals,” said Lance Alstodt, Chief Executive Officer of BioRestorative.

https://ih.advfn.com/stock-market/NASDAQ/biorestorative-therapies-BRTX/stock-news/93206255/biorestorative-therapies-presents-preliminary-clin

$BRTX BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

BioRestorative Therapies, Inc. (“BioRestorative”, “$BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced the public availability of a poster, presented yesterday at the Orthopaedic Research Society (ORS) 2024 Annual Meeting, which describes preliminary 26 and 52 week blinded data from the ongoing Phase 2 clinical trial of the Company’s lead clinical candidate, BRTX-100, in subjects with chronic lumbar disc disease (“cLDD”).
The presented poster, titled “Autologous Stem Cell Therapy for Chronic Lumbar Disc Disease; Initial Phase 2 Clinical Safety and Feasibility Data of Intradiscal Injections of Hypoxic Cultured Mesenchymal Stem Cells” can be accessed on the Company’s website at www.biorestorative.com under “Scientific Publications” in the Product Candidate section. During a webcasted conference call scheduled for 8:30am EST today, BioRestorative management will be available to discuss data from the presentation as well as provide a clinical update.

Previous clinical studies have demonstrated that the harsh microenvironment of the disc could impact cell dose viability and result in a non-efficacious or the worsening of clinical outcomes. Although this is blinded and early clinical data, it is important to note that the Visual Analog Scale, Oswestry Disability Index, Roland Morris Disability Questionnaire, and Functional Rating Index collected at weeks 26 and 52 post-injection demonstrated a positive trend compared to baseline. In addition to safety outcomes, changes to these pain and function scales compared to baseline are used by the U.S. Food and Drug Administration (FDA) to determine whether the trial will be allowed to proceed and ultimately gain Biologics License Application (BLA) approval.

“We are thrilled with the progress of our ongoing clinical development programs. With regard to the Phase 2 study investigating the use of BRTX-100 in the treatment of cLDD, we are strongly encouraged by the preliminary data presented at ORS 2024. The preliminary clinical data shows meaningful signals in patients enrolled in the study and, importantly, no notable safety signals,” said Lance Alstodt, Chief Executive Officer of BioRestorative.

$PVSP going higher

Nice list Mick !